Fingerprint
Dive into the research topics of 'Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma
Adi Diab, Scott S. Tykodi, Gregory A. Daniels, Michele Maio, Brendan D. Curti, Karl D. Lewis, Sekwon Jang, Ewa Kalinka, Igor Puzanov, Alexander I. Spira, Daniel C. Cho, Shanhong Guan, Erika Puente, Tuan Nguyen, Ute Hoch, Sue L. Currie, Wei Lin, Mary A. Tagliaferri, Jonathan Zalevsky, Mario Sznol
Research output: Contribution to journal › Article › peer-review